Skip to main content
. 2021 Nov 12;62(2):491–496. doi: 10.47162/RJME.62.2.15

Table 2.

Genotyping results and inheritance models calculations

rs41423247 NR3C1:c.1184+646C>G

rs6265 BDNF:c.442G>A

Genotype

MDD (%, n)

Control (%, n)

Genotype

MDD (%, n)

Control (%, n)

CC

46.34%, n=38

49.30%, n=141

GG

63.41%, n=52

60.69%, n=173

CG

40.24%, n=33

43.01%, n=123

GA

34.15%, n=28

34.42%, n=99

GG

13.41%, n=11

7.69%, n=22

AA

2.44%, n=2

4.90%, n=14

 

HWE, p=0.38

HWE, p=0.50

 

HWE, p=0.43

HWE, p=0.97

Dominant model

OR=1.13, 95%CI: (0.69, 1.84); χ2=0.12, p=0.72

Dominant model

OR=0.88, 95%CI: (0.53, 1.47); χ2=0.12, p=0.73

Recessive model

OR=1.86, 95%CI: (0.86, 4.01); χ2=1.90, p=0.16

Recessive model

OR=0.49, 95%CI: (0.11, 2.18); χ2=0.43, p=0.51

Allelic model

OR=1.22, 95%CI: (0.84, 1.77); χ2=0.94, p=0.33

Allelic model

OR=0.85, 95%CI: (0.55, 1.31); χ2=0.40, p=0.53

BDNF: Brain-derived neurotrophic factor; CI: Confidence interval; HWE: Hardy–Weinberg equilibrium; MDD: Major depressive disorder; n: No. of cases; NR3C1: Nuclear receptor subfamily 3 group C member 1; OR: Odds ratio